Scientific Supporters for
Clinical Excellence

Bayer AG is a global leader in cardiovascular pharmaceuticals and a strategic partner in the amyloidosis space. The collaboration focuses on patient identification pathways — ensuring that patients identified by SYGNAL receive timely access to approved therapies. This partnership positions MYCOR at the critical interface between diagnostics and therapeutics.

• Patient access programs
• Integrated diagnostic-therapeutic pathway
• Market access collaboration

The University Hospital Essen (Westdeutsches Herz- und Gefäßzentrum) is one of Germany's largest cardiovascular centers. Our clinical collaboration with the cardiology department provides real-world validation data for the SYGNAL algorithm — anchoring our AI in clinical practice.

• Clinical validation studies
• Access to high-volume HFpEF and ATTR-CM cohorts
• Peer-reviewed data pipeline

In collaboration with Goethe University Frankfurt, we conduct foundational research in cardiac biomarker analysis and algorithm-driven pattern recognition. The partnership bridges academic excellence and clinical translation — accelerating the path from research to regulatory approval.

• Foundational AI research
• Biomarker discovery
• Academic publication pipeline